French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)

Bernd Gänsbacher, Olivier Danos, George Dickson, Kris Thielemans, François Loic Cosset, Nicole Deglon, M. Sirac Dilber, Eithan Galun, David Klatzmann, Fulvio Mavilio, Naomi Taylor

Research output: Contribution to journalArticlepeer-review

28 Scopus citations
Original languageAmerican English
Pages (from-to)82-84
Number of pages3
JournalJournal of Gene Medicine
Issue number1
StatePublished - Jan 2003

Cite this